Nova Eye Medical Limited (ASX:EYE)
Australia · Delayed Price · Currency is AUD 0.1400
+0.0050 (3.70%)
Sep 17, 2026, 3:53 PM AEST
Nova Eye Medical Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 34.87 | 29.27 | 23.33 | 17.03 | 13.38 |
| 34.87 | 29.27 | 23.33 | 17.03 | 13.38 | |
Revenue Growth | 19.13% | 25.47% | 37.00% | 27.26% | -0.12% |
Cost of Revenue | 9.85 | 10.38 | 6.5 | 2.63 | 2.29 |
Gross Profit | 25.01 | 18.89 | 16.83 | 14.39 | 11.09 |
Selling, General & Admin | 22.2 | 19.63 | 16.8 | 21.87 | 17.4 |
Research & Development | 2.2 | 3.24 | 3.97 | - | - |
Other Operating Expenses | 4.98 | 5 | 5.03 | 2.01 | 1.58 |
Operating Expenses | 29.39 | 27.87 | 25.8 | 26.17 | 20.79 |
Operating Income | -4.38 | -8.99 | -8.97 | -11.78 | -9.7 |
Interest Expense | -0.15 | -0.16 | -0.07 | -0.05 | -0.06 |
Interest & Investment Income | 0.03 | 0.08 | 0.12 | 0.1 | 0.03 |
Currency Exchange Gain (Loss) | - | - | - | 0.14 | -0.05 |
Other Non Operating Income (Expenses) | 0.17 | - | 0.13 | 0.63 | 0.54 |
EBT Excluding Unusual Items | -4.33 | -9.06 | -8.79 | -10.96 | -9.24 |
Asset Writedown | - | - | - | -6.04 | - |
Other Unusual Items | - | - | - | - | 1.42 |
Pretax Income | -4.33 | -9.06 | -8.79 | -17 | -7.82 |
Income Tax Expense | - | - | - | -1.71 | -0.32 |
Earnings From Continuing Operations | -4.33 | -9.06 | -8.79 | -15.29 | -7.5 |
Net Income | -4.33 | -9.06 | -8.79 | -15.29 | -7.5 |
Net Income to Common | -4.33 | -9.06 | -8.79 | -15.29 | -7.5 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 285 | 247 | 204 | 156 | 145 |
Shares Outstanding (Diluted) | 285 | 247 | 204 | 156 | 145 |
Shares Change | 15.03% | 21.16% | 30.89% | 7.83% | 0.69% |
EPS (Basic) | -0.02 | -0.04 | -0.04 | -0.10 | -0.05 |
EPS (Diluted) | -0.02 | -0.04 | -0.04 | -0.10 | -0.05 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -3.38 | -6.45 | -8.07 | -7.09 | -4.85 |
Free Cash Flow Per Share | -0.01 | -0.03 | -0.04 | -0.04 | -0.03 |
Gross Margin | 71.74% | 64.54% | 72.15% | 84.55% | 82.89% |
Operating Margin | -12.55% | -30.70% | -38.47% | -69.19% | -72.50% |
Profit Margin | -12.43% | -30.95% | -37.69% | -89.83% | -56.03% |
Free Cash Flow Margin | -9.70% | -22.03% | -34.59% | -41.63% | -36.27% |
EBITDA | -3.41 | -7.93 | -7.2 | -9.48 | -7.89 |
EBITDA Margin | -9.79% | -27.08% | -30.86% | -55.69% | -58.96% |
D&A For EBITDA | 0.96 | 1.06 | 1.78 | 2.3 | 1.81 |
EBIT | -4.38 | -8.99 | -8.97 | -11.78 | -9.7 |
EBIT Margin | -12.55% | -30.70% | -38.47% | -69.19% | -72.50% |
Advertising Expenses | - | - | - | 3.2 | 1.78 |